Cargando…

Tissue transglutaminase in astrocytes is enhanced by inflammatory mediators and is involved in the formation of fibronectin fibril-like structures

BACKGROUND: During multiple sclerosis (MS) lesion formation, inflammatory mediators are produced by microglial cells and invading leukocytes. Subsequently, hypertrophic astrocytes fill the lesion and produce extracellular matrix (ECM) proteins that together form the astroglial scar. This is benefici...

Descripción completa

Detalles Bibliográficos
Autores principales:	Espitia Pinzón, Nathaly, Brevé, John J. P., Bol, John G. J. M., Drukarch, Benjamin, Baron, Wia, van Dam, Anne-Marie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745633/ https://www.ncbi.nlm.nih.gov/pubmed/29282083 http://dx.doi.org/10.1186/s12974-017-1031-2

Ejemplares similares

Astrocyte-derived tissue Transglutaminase affects fibronectin deposition, but not aggregation, during cuprizone-induced demyelination
por: Espitia Pinzon, Nathaly, et al.
Publicado: (2017)

Tissue Transglutaminase Promotes Early Differentiation of Oligodendrocyte Progenitor Cells
por: Espitia Pinzon, Nathaly, et al.
Publicado: (2019)

Astrocyte-Derived Tissue Transglutaminase Interacts with Fibronectin: A Role in Astrocyte Adhesion and Migration?
por: van Strien, Miriam E., et al.
Publicado: (2011)

Tissue Transglutaminase in Marmoset Experimental Multiple Sclerosis: Discrepancy between White and Grey Matter
por: Espitia Pinzon, Nathaly, et al.
Publicado: (2014)

Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis
por: Chrobok, Navina L., et al.
Publicado: (2018)

Absence of tissue transglutaminase reduces amyloid‐beta pathology in APP23 mice
por: Wilhelmus, Micha M. M., et al.
Publicado: (2022)

Tissue Transglutaminase Appears in Monocytes and Macrophages but Not in Lymphocytes in White Matter Multiple Sclerosis Lesions
por: Chrobok, Navina L, et al.
Publicado: (2019)

Correction: Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis
por: Chrobok, Navina L., et al.
Publicado: (2018)

TLR3 agonists induce fibronectin aggregation by activated astrocytes: a role of pro-inflammatory cytokines and fibronectin splice variants
por: Werkman, Inge, et al.
Publicado: (2020)

Differential Expression of Tissue Transglutaminase Splice Variants in Peripheral Blood Mononuclear Cells of Primary Progressive Multiple Sclerosis Patients
por: Sestito, Claudia, et al.
Publicado: (2018)

Tissue Transglutaminase Expression Associates With Progression of Multiple Sclerosis
por: Sestito, Claudia, et al.
Publicado: (2021)

Is monocyte- and macrophage-derived tissue transglutaminase involved in inflammatory processes?
por: Chrobok, Navina L., et al.
Publicado: (2016)

In vivo evaluation of two tissue transglutaminase PET tracers in an orthotopic tumour xenograft model
por: van der Wildt, Berend, et al.
Publicado: (2018)

The EIIIA domain from astrocyte‐derived fibronectin mediates proliferation of oligodendrocyte progenitor cells following CNS demyelination
por: Stoffels, Josephine M. J., et al.
Publicado: (2014)

The Transglutaminase-2 Interactome in the APP23 Mouse Model of Alzheimer’s Disease
por: Wilhelmus, Micha M. M., et al.
Publicado: (2022)

Monocyte-derived tissue transglutaminase in multiple sclerosis patients: reflecting an anti-inflammatory status and function of the cells?
por: Sestito, Claudia, et al.
Publicado: (2017)

Monocyte behaviour and tissue transglutaminase expression during experimental autoimmune encephalomyelitis in transgenic CX3CR1(gfp/gfp) mice
por: Chrobok, Navina L., et al.
Publicado: (2016)

Tissue Transglutaminase Is an Integrin-Binding Adhesion Coreceptor for Fibronectin
por: Akimov, Sergey S., et al.
Publicado: (2000)

Small Molecule Inhibitors Target the Tissue Transglutaminase and Fibronectin Interaction
por: Yakubov, Bakhtiyor, et al.
Publicado: (2014)

Fibronectin binding site in type I collagen regulates fibronectin fibril formation
Publicado: (1993)

Targeting Fibronectin to Overcome Remyelination Failure in Multiple Sclerosis: The Need for Brain- and Lesion-Targeted Drug Delivery
por: van Schaik, Pauline E. M., et al.
Publicado: (2022)

Impairing committed cholesterol biosynthesis in white matter astrocytes, but not grey matter astrocytes, enhances in vitro myelination
por: Werkman, Inge L., et al.
Publicado: (2020)

Fibronectin aggregates promote features of a classically and alternatively activated phenotype in macrophages
por: Sikkema, Arend H., et al.
Publicado: (2018)

Transglutaminase-2 Interaction with Heparin: IDENTIFICATION OF A HEPARIN BINDING SITE THAT REGULATES CELL ADHESION TO FIBRONECTIN-TRANSGLUTAMINASE-2 MATRIX
por: Lortat-Jacob, Hugues, et al.
Publicado: (2012)

Abstract 173: 3D Transglutaminase Fibronectin Hydrogel For The Treatment Of Skin Wounds
por: Raghuram, Anjali C., et al.
Publicado: (2020)

Strategies towards in vivo imaging of active transglutaminase type 2 using positron emission tomography
por: van der Wildt, Berend, et al.
Publicado: (2016)

3D Transglutaminase Fibronectin Hydrogel Therapy for Healing of Chronic Irradiated Porcine Skin Wounds
por: Raghuram, Anjali, et al.
Publicado: (2021)

Catalytically active tissue transglutaminase colocalises with Aβ pathology in Alzheimer’s disease mouse models
por: Wilhelmus, Micha M. M., et al.
Publicado: (2016)

Brain region-specific gene expression profiles in freshly isolated rat microglia
por: Doorn, Karlijn J., et al.
Publicado: (2015)

MMP7 cleaves remyelination‐impairing fibronectin aggregates and its expression is reduced in chronic multiple sclerosis lesions
por: Wang, Peng, et al.
Publicado: (2018)

Toll-like Receptor 4 Is Upregulated in Parkinson’s Disease Patients and Co-Localizes with pSer129αSyn: A Possible Link with the Pathology
por: Conte, Carmela, et al.
Publicado: (2023)

Molecular architecture of native fibronectin fibrils
por: Früh, Susanna Maria, et al.
Publicado: (2015)

5: 3D Transglutaminase Fibronectin Hydrogel Therapy Improves the Healing of Chronic Irradiated Porcine Skin Wounds
por: Raghuram, Anjali C., et al.
Publicado: (2021)

Discrepancy in CCL2 and CCR2 expression in white versus grey matter hippocampal lesions of Multiple Sclerosis patients
por: Prins, Marloes, et al.
Publicado: (2014)

Transglutaminase 3: The Involvement in Epithelial Differentiation and Cancer
por: Chermnykh, Elina S., et al.
Publicado: (2020)

A novel fibronectin binding site required for fibronectin fibril growth during matrix assembly
por: Sechler, Jan L., et al.
Publicado: (2001)

In silico-in vitro modeling to uncover cues involved in establishing microglia identity: TGF-β3 and laminin can drive microglia signature gene expression
por: Timmerman, Raissa, et al.
Publicado: (2023)

Heparan sulfate is necessary for the early formation of nascent fibronectin and collagen I fibrils at matrix assembly sites
por: Hill, Katherine E., et al.
Publicado: (2021)

Deletion or Inhibition of Astrocytic Transglutaminase 2 Promotes Functional Recovery after Spinal Cord Injury
por: Elahi, Anissa, et al.
Publicado: (2021)

Transcriptional heterogeneity between primary adult grey and white matter astrocytes underlie differences in modulation of in vitro myelination
por: Werkman, Inge L., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ubqudi7vcr645q8thlfu4chg00